oxymatrine has been researched along with d-alpha tocopherol in 1 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (d-alpha tocopherol) | Trials (d-alpha tocopherol) | Recent Studies (post-2010) (d-alpha tocopherol) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 32,198 | 2,903 | 7,258 |
| Protein | Taxonomy | oxymatrine (IC50) | d-alpha tocopherol (IC50) |
|---|---|---|---|
| Glutathione S-transferase P | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, L; Shan, W; Shu, D; Wang, H; Wang, T; Wu, J; Xiong, S; Zhang, S | 1 |
1 other study(ies) available for oxymatrine and d-alpha tocopherol
| Article | Year |
|---|---|
Liposomal oxymatrine in hepatic fibrosis treatment: formulation, in vitro and in vivo assessment.
Topics: Alkaloids; Animals; Carbon Tetrachloride; Chemistry, Pharmaceutical; Cytoprotection; Dimethylnitrosamine; Drug Carriers; Kinetics; Liposomes; Liver; Liver Cirrhosis, Experimental; Male; Mice, Inbred ICR; Protective Agents; Quinolizines; Solubility; Technology, Pharmaceutical; Vitamin E | 2014 |